» Articles » PMID: 37605742

Improvement of Corneal Nerve Regeneration in Diabetic Rats Using Wharton's Jelly-Derived Mesenchymal Stem Cells and Their Conditioned Medium

Overview
Specialty Genetics
Date 2023 Aug 22
PMID 37605742
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the efficacy of Wharton's jelly mesenchymal stem cells (WJSCs) and their conditioned medium (CM) for corneal nerve regeneration in rats with diabetic keratopathy. Streptozotocin (STZ)-induced male diabetic (DM) rats (250-300 g) were divided into four groups (n=7/group): Control, DM, DM with WJSCs (DM+WJ), and DM with CM treatment (DM+CM). DM+WJ and DM+CM group received WJSCs or CM, respectively, topically with eye drops. Corneal sensibility, corneal epithelial layer integrity, histology, expression of GAP-43 and TUBB3 on mRNA level and their immunohistochemical expression were examined after two weeks of treatment. There were changes in corneal sensibility and corneal integrity between normal control and diabetic groups with/without WJSC or CM injection. Total central corneal thickness was significantly higher in DM+CM (249.81 ± 43.85 μm) than in control (174.72 ± 44.12 μm, P=0.004) and DM groups (190.15 ± 9.63 μm, P=0.03). GAP-43 mRNA expression levels of DM+WJ and DM+CM groups were higher compared with DM and control groups. TUBB3 mRNA level was increased after CM (P=0.047), but not after WJSCs treatment (P=1.00). GAP-43 and TUBB3 immunohistochemical expression of nerve fibers along the epithelial layer significantly increased in DM+WJ and DM+CM compared with DM group. Our findings showed that WJSCs and their CM improved corneal nerve regeneration in rats with diabetic keratopathy.

References
1.
Fong C, Chak L, Biswas A, Tan J, Gauthaman K, Chan W . Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev Rep. 2010; 7(1):1-16. DOI: 10.1007/s12015-010-9166-x. View

2.
Lee M, Ko A, Ko J, Lee H, Kim M, Wee W . Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye. Mol Ther. 2014; 23(1):139-46. PMC: 4426793. DOI: 10.1038/mt.2014.159. View

3.
Hosseini S, Taghiyar L, Safari F, Baghaban Eslaminejad M . Regenerative Medicine Applications of Mesenchymal Stem Cells. Adv Exp Med Biol. 2018; 1089:115-141. DOI: 10.1007/5584_2018_213. View

4.
Beyazyildiz E, Pinarli F, Beyazyildiz O, Hekimoglu E, Acar U, Demir M . Efficacy of topical mesenchymal stem cell therapy in the treatment of experimental dry eye syndrome model. Stem Cells Int. 2014; 2014:250230. PMC: 4127226. DOI: 10.1155/2014/250230. View

5.
Take G, Karabay G, Erdogan D, Duyar I . The ultrastructural alterations in rat corneas with experimentally-induced diabetes mellitus. Saudi Med J. 2006; 27(11):1650-5. View